BioNTech SE (BNTX) Gross Profit (QoQ) (2018 - 2025)
BioNTech SE (BNTX) Gross Profit (QoQ) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
BioNTech SE |
27.38 Bn |
10.07 Bn |
668.28 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
-58.29% |
| Sep 30, 2025 |
2,163.43% |
| Jun 30, 2025 |
-21.82% |
| Mar 31, 2025 |
-100.00% |
| Dec 31, 2024 |
301,124.01% |
| Sep 30, 2024 |
1,477.67% |
| Jun 30, 2024 |
236.87% |
| Mar 31, 2024 |
-103.88% |
| Dec 31, 2023 |
75.16% |
| Sep 30, 2023 |
15,176.56% |
| Jun 30, 2023 |
-99.59% |
| Mar 31, 2023 |
-69.66% |
| Dec 31, 2022 |
52.98% |
| Sep 30, 2022 |
5.23% |
| Jun 30, 2022 |
-54.49% |
| Mar 31, 2022 |
0.71% |
| Dec 31, 2021 |
-1.53% |
| Sep 30, 2021 |
7.91% |
| Jun 30, 2021 |
100.26% |
| Mar 31, 2021 |
-100.50% |
